Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Thermo Fisher Scientific Inc (TMO)

Thermo Fisher Scientific Inc (TMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 186,670,544
  • Shares Outstanding, K 395,589
  • Annual Sales, $ 25,542 M
  • Annual Income, $ 3,696 M
  • 60-Month Beta 0.98
  • Price/Sales 7.38
  • Price/Cash Flow 26.36
  • Price/Book 5.93
Trade TMO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 5.63
  • Number of Estimates 8
  • High Estimate 6.03
  • Low Estimate 4.85
  • Prior Year 3.55
  • Growth Rate Est. (year over year) +58.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
433.01 +9.26%
on 10/02/20
490.71 -3.58%
on 10/27/20
+31.60 (+7.16%)
since 09/30/20
3-Month
401.07 +17.97%
on 09/04/20
490.71 -3.58%
on 10/27/20
+62.56 (+15.24%)
since 07/30/20
52-Week
250.21 +89.09%
on 03/23/20
490.71 -3.58%
on 10/27/20
+171.26 (+56.73%)
since 10/30/19

Most Recent Stories

More News
Amedisys (AMED) Beats Q3 Earnings Estimates, Ups 2020 View

An impressive Q3 performance by Amedisys' (AMED) Home health and hospice amid the pandemic-led business disruptions buoys optimism.

AMED : 259.00 (+3.24%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
WST : 272.07 (-1.15%)
Integer Holdings (ITGR) Q3 Earnings Beat Estimates, Down Y/Y

Integer Holdings' (ITGR) third-quarter results reflect weak segmental performance.

ANGO : 10.34 (-3.00%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
ITGR : 58.45 (-4.23%)
Bio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Rise

Bio-Rad's (BIO) third-quarter 2020 results reflect strong performance by the Life Science segment, boosted by coronavirus-led increased testing demand.

ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
WST : 272.07 (-1.15%)
BIO : 586.42 (+3.24%)
Stryker (SYK) Q3 Earnings and Revenues Surpass Estimates

Stryker's (SYK) third-quarter earnings reflect strong segmental performance.

SYK : 202.01 (-1.65%)
ANGO : 10.34 (-3.00%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MMSI : 50.05 (-2.99%)
ABC : 96.07 (+1.56%)
LH : 199.77 (+0.13%)
TMO : 473.12 (+0.26%)
Merit Medical (MMSI) Rallies 4.8% Post Q3 Earnings Beat

Merit Medical (MMSI) reported growth in revenues at Cardiovascular segment in the third quarter.

ANGO : 10.34 (-3.00%)
MMSI : 50.05 (-2.99%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
DaVita (DVA) Earnings Beat Estimates in Q3, Revenues Miss

DaVita (DVA) saw strength in dialysis services in the United States in the third quarter.

ANGO : 10.34 (-3.00%)
DVA : 86.25 (+0.56%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
The Zacks Analyst Blog Highlights: Thermo Fisher, SAP, BMY, NextEra and Morgan Stanley

The Zacks Analyst Blog Highlights: Thermo Fisher, SAP, BMY, NextEra and Morgan Stanley

MS : 48.15 (+0.06%)
NEE : 73.21 (-1.08%)
BMY : 58.45 (+0.92%)
TMO : 473.12 (+0.26%)
SAP : 106.83 (-1.66%)
Integra (IART) Q3 Earnings Surpass Estimates, Margins Up

Integra's (IART) third-quarter 2020 results reflect mixed segmental performance with strong recovery trends due to coronavirus-led business disruptions.

IART : 44.10 (+1.82%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
WST : 272.07 (-1.15%)
Globus Medical (GMED) Q3 Earnings Beat, U.S. Business Strong

Globus Medical's (GMED) spinal implant business performance varies by region in Q3.

ANGO : 10.34 (-3.00%)
ALGN : 426.08 (-2.40%)
TMO : 473.12 (+0.26%)
GMED : 52.12 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab...

See More

Key Turning Points

2nd Resistance Point 481.33
1st Resistance Point 477.23
Last Price 473.12
1st Support Level 467.26
2nd Support Level 461.39

See More

52-Week High 490.71
Last Price 473.12
Fibonacci 61.8% 398.84
Fibonacci 50% 370.46
Fibonacci 38.2% 342.08
52-Week Low 250.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar